244 Results for "

programmed

" in MedChemExpress (MCE) Product Catalog:
Products (244)

244 Results for "programmed" in MCE Product Catalog:

Cat. No.: HY-101058A
Purity:  95.11%
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PD1-PDL1-IN 1 TFA (compound 16) is a potent programmed cell death 1 (PD-1) inhibitor. PD1-PDL1-IN 1 TFA is useful as immune modulator .
loading...
    loading...
Cat. No.: HY-101097
CAS No.: 1673560-66-1
Purity:  99.57%
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1-IN-17 is a programmed cell death-1 (PD-1) inhibitor extracted from patent WO2015033301A1, Compound 12, inhibits 92% splenocyte proliferation at 100 nM .
loading...
    loading...
Cat. No.: HY-115406A
CAS No.: 2321332-57-2
Target:  

Apoptosis

Research Areas:  

Cancer

CPTH6 hydrobromide is a thiazole derivative which activates apoptotic program and increases autophagic features in human acute myeloid leukemia cell lines. CPTH6 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-152944
CAS No.: 871340-88-4
Purity:  99.70%
Research Areas:  

Cancer

S6K1-IN-DG2 (Compound 66) is a p70S6K inhibitor (IC50: < 100 nM) .
loading...
    loading...
Cat. No.: HY-P99938
CAS No.: 2403647-03-8
Synonyms: HX008

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor .
loading...
    loading...
Cat. No.: HY-160596
CAS No.: 2409156-19-8
Synonyms: 5-Formyl-deoxycytidine lithium
Target:  

DNA/RNA Synthesis

Research Areas:  

Others

5-Formyl-dCTP (5-Formyl-deoxycytidine) lithium is a DCTPP1 substrate. 5-Formyl-dCTP lithium acts as a mutagen/epigenetic disruptor via DNA polymerase incorporation, mutagenic mispairings, and disturbed epigenetic programming. 5-Formyl-dCTP lithium can be used for research on genotoxicity .
loading...
    loading...
Cat. No.: HY-167935
CAS No.: 3029253-76-4
Target:  

Bacterial

LCC-12 formic is a dimer of metformin that targets mitochondrial copper(II), leading to a decrease in the NAD(H) pool and modulation of inflammatory responses. LCC-12 formic reduces inflammation in mouse models of bacterial and viral infections. LCC-12 formic also serves as a tool for investigating metabolic diseases through its effects on cell plasticity and epigenetic programming.
loading...
    loading...
Cat. No.: HY-128605
CAS No.: 2349372-98-9
Purity:  98.99%
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1-IN-22 is a potent programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) interaction inhibitor with an IC50 of 92.3 nM .
loading...
    loading...
Cat. No.: HY-138139B
CAS No.: 2479276-17-8
Purity:  99.76%
Synonyms: T785 trihydrochloride
Research Areas:  

Inflammation/Immunology Cancer

AXC-715 (T785) trihydrochloride is a TLR7/TLR8 dual agonist. AXC-715 trihydrochloride can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants .
loading...
    loading...
Cat. No.: HY-149393
CAS No.: 3052303-53-1
Purity:  95.98%
Research Areas:  

Cancer

RIPK3-IN-3 (compound 20) is a selective inhibitor of RIP kinase RIPK3 (IC50=10 nM). RIPK3 mediates the phosphorylation of Mixed Lineage Kinase (MLKL) and causes necroptosis, while RIPK3-IN-3 inhibits p-MLKL oligomerization and thereby inhibits necroptosis. RIPK3-IN-3 also downregulates CXCL5 secretion and inhibits AsPC-1 cell migration and invasion .
loading...
    loading...
Cat. No.: HY-178205
CAS No.: 2236595-58-5
Target:  

CXCR ERK Akt

Research Areas:  

Cancer

BPRCX 807 is a selective and potent CXCR4 (CXC chemokine receptor type 4) antagonist. BPRCX 807 inhibits CXCL12-mediated ERK and Akt phosphorylation. BPRCX 807 can significantly suppress primary tumor growth. BPRCX 807 can be used for the study of hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-P10950
CAS No.: 1931111-41-9
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PD-L1 inhibitory peptide is an inhibitor peptide targeting programmed cell death ligand 1 (PD-L1). PD-L1 inhibitory peptide binds to PD-L1, relieving immunosuppression and restoring the antitumor activity of T cells. PD-L1 inhibitory peptide is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-P991122
CAS No.: 3037124-22-1
Synonyms: ONO-4685

Target:  

PD-1/PD-L1 CD3

Research Areas:  

Inflammation/Immunology Cancer

Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3ε chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-147116
CAS No.: 87736-89-8
Purity:  99.06%
Research Areas:  

Others

4-[3-(Trifluoromethyl)diazirin-3-yl] benzoic acid N-hydroxysuccinimide ester is a photoactivated bifunctional cross-linker. 4-[3-(Trifluoromethyl)diazirin-3-yl] benzoic acid N-hydroxysuccinimide ester can be used for researching a strategy of rapid and accurate structure generation in support of antigen engineering programs .
loading...
    loading...
Cat. No.: HY-139047
CAS No.: 332063-87-3
Purity:  98.08%
Target:  

GLUT

Research Areas:  

Cancer

SW157765 is a selective non-canonical glucose transporter GLUT8 (SLC2A8) inhibitor. KRAS/KEAP1 double mutant NSCLC cells are selectively sensitive to the SW157765, due to the convergent consequences of dual KRAS and NRF2 modulation of metabolic and xenobiotic gene regulatory programs .
loading...
    loading...
Cat. No.: HY-34765
CAS No.: 7341-96-0
Propiolamide is a monooxygenase (MMO) system activator and glutathione peroxidase 4 (GPX4) inhibitor. Propiolamide induces ROS production through interaction with the MMO system. Propiolamide promotes the accumulation of intracellular cytotoxic lipid peroxides and induces ferroptosis. Propiolamide induces programmed cell death via the apoptosis pathway. Propiolamide can be used in cancer research .
loading...
    loading...
Cat. No.: HY-101058
CAS No.: 2005454-12-4
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

PD1-PDL1-IN 1 (compound 16) is a potent programmed cell death 1 (PD-1) inhibitor. PD1-PDL1-IN 1 is useful as immune modulator .
loading...
    loading...
Cat. No.: HY-144037
CAS No.: 2722645-10-3
Target:  

DNA-PK

Research Areas:  

Cancer

DNA-PK-IN-4 is a potent inhibitor of DNA-PK. DNA-PK-IN-4 is a imidazolinone derivative compound. DNA-PK-IN-4 inhibits DNA-PKcs activity, thus greatly reducing tumor DNA repair and inducing cells to enter the apoptotic program. DNA-PK-IN-4 has the potential for the research of cancer disease (extracted from patent WO2021209055A1, compound 27) .
loading...
    loading...
Cat. No.: HY-P990072
CAS No.: 2639481-06-2
Synonyms: LZM-009

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Lipustobart is an IgG4-kappa, anti-PDCD1 (programmed cell death 1, PD1, PD-1, CD279) humanized monoclonal antibody. Lipustobart shows immunostimulant and antineoplastic activity .
loading...
    loading...
Cat. No.: HY-P991147
CAS No.: 2769743-01-1

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Ledostomig is an immunoglobulin (H-γ1-scFv-L-κ) dimer monoclonal antibody targeting human netrin-5 (NTS5) and programmed death-1 (PD-1). Ledostomig is promising for research of various cancers .
loading...
    loading...